Guggenheim Maintains Buy on Endava, Lowers Price Target to $45
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Jonathan Lee maintains a Buy rating on Endava (NYSE:DAVA) but lowers the price target from $55 to $45.
September 16, 2024 | 4:46 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Guggenheim's analyst Jonathan Lee continues to recommend buying Endava shares but has reduced the price target from $55 to $45, indicating a more cautious outlook.
The Buy rating suggests confidence in Endava's long-term potential, but the lowered price target reflects a more cautious short-term outlook. This mixed signal may lead to neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100